8,351 Shares in CME Group Inc. $CME Bought by Winthrop Partners WNY LLC

Winthrop Partners WNY LLC purchased a new stake in CME Group Inc. (NASDAQ:CME) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 8,351 shares of the financial services provider’s stock, valued at approximately $2,280,000. CME Group comprises 1.2% of Winthrop Partners WNY LLC’s portfolio, making the stock its 28th biggest position.

Several other institutional investors have also added to or reduced their stakes in CME. Norges Bank bought a new stake in shares of CME Group in the fourth quarter valued at about $1,523,241,000. Sanders Capital LLC bought a new position in shares of CME Group during the third quarter worth about $1,006,932,000. Strive Asset Management LLC bought a new position in shares of CME Group during the third quarter worth about $636,487,000. Victory Capital Management Inc. raised its position in CME Group by 746.4% in the 4th quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock valued at $559,720,000 after buying an additional 1,807,491 shares during the last quarter. Finally, Life Cycle Investment Partners Ltd acquired a new stake in CME Group in the 4th quarter valued at approximately $217,656,000. 87.75% of the stock is owned by institutional investors.

CME Group Stock Performance

CME opened at $246.38 on Friday. CME Group Inc. has a 52-week low of $244.56 and a 52-week high of $329.16. The firm has a market capitalization of $89.28 billion, a PE ratio of 21.02, a PEG ratio of 2.75 and a beta of 0.21. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The business’s 50-day simple moving average is $279.61 and its 200 day simple moving average is $287.21.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period last year, the company earned $2.80 earnings per share. The business’s revenue was up 14.5% compared to the same quarter last year. As a group, sell-side analysts expect that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

Analysts Set New Price Targets

CME has been the subject of a number of recent research reports. Morgan Stanley reduced their price target on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a research report on Thursday, April 23rd. The Goldman Sachs Group lowered their price objective on shares of CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a report on Thursday, April 23rd. Weiss Ratings lowered shares of CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, June 11th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Finally, TD Cowen reduced their target price on shares of CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Twelve analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $305.18.

Insiders Place Their Bets

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by insiders.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
• Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
• Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
• Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
• Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.